Evofem Biosciences EPS - Earnings per Share 2013-2022 | EVFM

Evofem Biosciences eps - earnings per share from 2013 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Evofem Biosciences Annual EPS
2021 $-23.69
2020 $-31.78
2019 $-29.84
2018 $-86.06
2017 $-836.28
2016 $-84.86
2015 $-283.51
2014 $-482.06
2013 $-2,637.85
2012 $-1,407.52
Evofem Biosciences Quarterly EPS
2022-03-31 $-2.88
2021-12-31 $-3.98
2021-09-30 $-7.20
2021-06-30 $-4.05
2021-03-31 $-8.46
2020-12-31 $-6.60
2020-09-30 $-5.55
2020-06-30 $-13.64
2020-03-31 $-6.00
2019-12-31 $-0.75
2019-09-30 $-4.50
2019-06-30 $-14.54
2019-03-31 $-10.05
2018-12-31 $10.50
2018-09-30 $-10.65
2018-06-30 $-16.64
2018-03-31 $-69.27
2017-12-31 $-158.17
2017-09-30 $-574.36
2017-06-30 $-56.67
2017-03-31 $-47.08
2016-12-31 $-12.91
2016-09-30 $-15.29
2016-06-30 $-17.09
2016-03-31 $-39.57
2015-12-31 $-63.16
2015-09-30 $-113.32
2015-06-30 $-62.06
2015-03-31 $-44.97
2014-12-31 $-40.47
2014-09-30 $-657.44
2014-06-30 $-371.44
2014-03-31 $-269.81
2013-12-31 $0.00
2012-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.011B $0.008B
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $153.995B 9.34
GSK (GSK) United Kingdom $82.506B 9.91
Bio-Rad Laboratories (BIO.B) United States $16.008B 35.37
QIAGEN (QGEN) Netherlands $11.286B 18.90
Biohaven Pharmaceutical Holding (BHVN) United States $10.366B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.454B 0.00
Arcus Biosciences (RCUS) United States $1.972B 38.49
Emergent Biosolutions (EBS) United States $1.578B 9.15
Myovant Sciences (MYOV) United Kingdom $1.450B 0.00
Zymeworks (ZYME) Canada $0.376B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
Gelesis Holdings (GLS) United States $0.098B 0.00
SQZ Biotechnologies (SQZ) United States $0.095B 0.00
Ambrx Biopharma (AMAM) United States $0.091B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00